https://www.clinicaltrialsarena.com/news/newstakeda-seattle-genetics-report-positive-results-phase-iii-alcanza-trial-adcetris-treat-ctcl-4966342/
Takeda Pharmaceutical and Seattle Genetics have reported positive results from the Phase III ALCANZA clinical trial of Adcetris to treat cutaneous T-cell...
seattle geneticspositive resultsphase iiitakedareport
https://www.fool.com/investing/2017/06/26/why-shares-of-seattle-genetics-inc-got-whacked-tod.aspx
Sometimes good news isn't good enough.
seattle geneticssharesincgottoday
https://www.prnewswire.com/news-releases/seattle-genetics-and-astellas-announce-clinical-trial-collaboration-with-merck-to-evaluate-enfortumab-vedotin-in-combination-with-keytruda-pembrolizumab-in-patients-with-metastatic-urothelial-cancer-300967128.html
/PRNewswire/ -- Seattle Genetics, Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas"), today...
seattle geneticsclinical trialastellasannouncecollaboration